SG Americas Securities
IDXX icon

SG Americas Securities’s Idexx Laboratories IDXX Stock Holding History

SG Americas Securities’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-13,000
Closed -$143K – 3348
2024
Q3 		$143K Hold
13,000
– – ﹤0.01% 2774
2024
Q2 		$156K Hold
13,000
– – ﹤0.01% 2294
2024
Q1 		$614K Buy
+13,000
New +$7.1M ﹤0.01% 1335

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

SG Americas Securities's IDXX Position: Q2 2026 in Review

SG Americas Securities increased its Idexx Laboratories (IDXX) stake by 726% in Q2 2026, buying an estimated $43.3M and bringing the position to 87,840 shares worth $46.2M. The position accounts for 0.03% of the portfolio, ranked #368.

SG Americas Securities first reported a position in IDXX in Q2 2013 and has held it in 53 quarters since. The position peaked at $58.2M in Q1 2025. 1,306 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • SG Americas Securities held 87,840 shares of Idexx Laboratories worth $46.2M as of Q2 2026.
  • SG Americas Securities bought 77,209 Idexx Laboratories shares in Q2 2026, an estimated $43.3M.
  • Idexx Laboratories made up 0.03% of SG Americas Securities's portfolio in Q2 2026, its #368 holding.
  • SG Americas Securities first reported a position in Idexx Laboratories in Q2 2013 and has held it in 53 quarters since.
  • SG Americas Securities's Idexx Laboratories position peaked at $58.2M in Q1 2025.
  • 1,306 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.